United Community Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.2K | Buy |
166
+50
| +43% | +$26.3K | 0.03% | 265 |
|
|
2025
Q1 | $73.6K | Buy |
116
+20
| +21% | +$12.7K | 0.03% | 284 |
|
|
2024
Q4 | $68.4K | Hold |
96
| – | – | 0.03% | 280 |
|
|
2024
Q3 | $101K | Sell |
96
-29
| -23% | -$30.5K | 0.04% | 247 |
|
|
2024
Q2 | $131K | Hold |
125
| – | – | 0.05% | 229 |
|
|
2024
Q1 | $120K | Sell |
125
-5
| -4% | -$4.81K | 0.05% | 229 |
|
|
2023
Q4 | $114K | Hold |
130
| – | – | 0.05% | 234 |
|
|
2023
Q3 | $107K | Buy |
130
+15
| +13% | +$12.3K | 0.05% | 209 |
|
|
2023
Q2 | $82.6K | Buy |
115
+10
| +10% | +$7.19K | 0.07% | 156 |
|
|
2023
Q1 | $86.3K | Hold |
105
| – | – | 0.08% | 131 |
|
|
2022
Q4 | $75.8K | Sell |
105
-25
| -19% | -$18K | 0.07% | 144 |
|
|
2022
Q3 | $89.6K | Buy |
130
+40
| +44% | +$27.6K | 0.09% | 122 |
|
|
2022
Q2 | $53.2K | Sell |
90
-10
| -10% | -$5.91K | 0.06% | 159 |
|
|
2022
Q1 | $69.8K | Hold |
100
| – | – | 0.07% | 148 |
|
|
2021
Q4 | $63.2K | Buy |
+100
| New | +$63.2K | 0.06% | 153 |
|